Filing Details
- Accession Number:
- 0001641172-25-003951
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-14 06:30:30
- Reporting Period:
- 2025-04-11
- Filing Date:
- 2025-04-14
- Accepted Time:
- 2025-04-14 06:30:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1574094 | Renovorx Inc. | RNXT | Pharmaceutical Preparations (2834) | 271448452 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1862617 | Ramtin Agah | C/O Renovorx, Inc. 2570 W El Camino Real, Suite 320 Mountain View CA 94040 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-04-11 | 20,000 | $0.80 | 1,098,460 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects open market purchases of the Issuer's securities.